Mario Gonzalez

Title: Mario Gonzalez and Pharmaceutical Patent Innovation

Introduction

Mario Gonzalez is an inventor associated with Winchester, Massachusetts, and Medicis Pharmaceutical Corporation. His patent work concerns crystalline and liquid crystalline forms of 25-hydroxy-cholest-5-en-3-sulfate sodium, also known as 25HC3S sodium, and methods for preparing the compound.

Latest Patents

Gonzalez is credited with 1 patent: “Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same.” The patent describes Forms I, II, III, V, IX, XI, and XIII of 25HC3S sodium, as well as combinations of those forms. It also covers pharmaceutical formulations and methods of preparing 25HC3S.

The disclosed methods of treatment or prevention address conditions including hypercholesterolemia, hypertriglyceridemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, alcoholic hepatitis, acute kidney injury, psoriasis, and atherosclerosis. The patent’s focus is the compound’s forms, preparation, and potential pharmaceutical applications.

Career Highlights

Gonzalez’s listed patent is connected to Medicis Pharmaceutical Corporation and reflects work at the intersection of pharmaceutical chemistry and drug formulation. Its subject matter includes both the preparation of distinct crystalline forms and their potential use in pharmaceutical compositions.

Collaborations

Andrew R. Miksztal and Shawn Johnstone are identified as Gonzalez’s coworkers. Their names provide context for the professional network associated with his work.

Conclusion

Mario Gonzalez’s patent contribution centers on 25HC3S sodium, its crystalline and liquid crystalline forms, and potential pharmaceutical applications for a range of health conditions.